Jenga Biosciences

Each year, over 6 million dogs are diagnosed with cancer, a figure that notably exceeds the 1.9 million human cancer incidence rate. In the U.S., there are merely nine approved cancer treatments for veterinary use, many of which rely on outdated technologies. This scarcity is compounded by limited insurance coverage, hindering access to crucial care for numerous pets and their families. Jenga is on a mission to arm veterinarians with cutting-edge, effective cancer treatments. We strive to broaden the accessibility of advanced cancer care for pets in need, aiming to transform the landscape of veterinary oncology. Committed to overcoming existing barriers in cancer treatment, Jenga is forging a path toward a future where all pets can enjoy healthier, fuller lives. By expanding therapeutic innovations, we seek to improve health outcomes for pets, providing their families with reassurance and hope. Through relentless innovation and unwavering dedication, Jenga is set to elevate veterinary care, guaranteeing the best possible treatments are within reach for pets everywhere.